India, WHO in quid pro quo to resume vaccine exports

JAIPUR – India is increasingly at the center of the global debate over how to get more Covid-19 vaccine shots in developing world arms.

Last week, the World Health Organization granted emergency approval to India’s indigenously developed and produced Covaxin vaccine, a long-awaited designation that has cleared some of the controversy around the jab.

The WHO said the jab’s benefits far outweigh its risks. The approval comes as global health body aims to rejuvenate its COVAX vaccine distribution platform, which seeks to improve access to poor global countries.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *